• Corpus ID: 189169197

Psoriyazis vulgarisli olgularda kullanılan tedavi yöntemlerinin etkinliklerinin değerlendirilmesi

  title={Psoriyazis vulgarisli olgularda kullanılan tedavi y{\"o}ntemlerinin etkinliklerinin değerlendirilmesi},
  author={Ozlem Ozbagcivan and Sevgi Akarsu and Turna Ilknur and Serap Maden and Emel Fetil},
Amac: Psoriyazis vulgarisin tedavisinde topikal preparatlar, foto(kemo)terapi, geleneksel sistemik ajanlar ve biyolojik ajan tedavilerini iceren cesitli secenekler kullanilmaktadir.Psoriyazis vulgariste artrit gibi sistemik tutulumlarin yani sira yasam kalitesi duzeylerinde azalma ve psikolojik etkilenimlerin olmasi, bu hastaliktaki etkin tedavi yontemlerinin seciminin onemini vurgulamaktadir. Bu calismada klinigimizde yatirilarak tetkik ve tedavi edilen psoriyazis vulgarisli olgularda… 


Efficacy and Safety of Tripterygium wilfordii Hook F Versus Acitretin in Moderate to Severe Psoriasis Vulgaris: A Randomized Clinical Trial
There was no significant difference in treatment efficacy between the Tw HF and acitretin groups within 8 weeks, but there were fewer treatment-related adverse events in the TwHF group.
Options and opportunities for clinical management and treatment of psoriasis.
Insight is provided into various psoriasis treatment strategies-from conventional to novel-currently in use or in development as well as the novel targets that have been explored and/or investigated for anti-psoriatic therapy.
Effect of Narrow Band Ultraviolet B Therapy versus Methotrexate on Serum Levels of Interleukin-17 and Interleukin-23 in Egyptian Patients with Severe Psoriasis
Interleukin-17 and IL-23 serum level may serve as a potential biomarker for predicting the prognosis and therapeutic response of NB-UVB or MTX in treating psoriasis.
[Cyclosporine and psoriasis: experience with 14 patients].
It is concluded that cyclosporine is beneficial in psoriasis but there is a relapse once the treatment is discontinued, and the recommended dosage is 5 mg/kg/day.
Clinical spectrum and severity of psoriasis.
The clinical spectrum of psoriasis, the differential diagnoses, measures and determinants of severity, and the recommendations on when to refer a patient to a specialist in psoriatic disease are reviewed.
Management of psoriasis in adolescence
The management of psoriasis in adolescence is an intriguing and complicated task and physicians must rely on published experience from case reports both from the field of dermatology as well as from the application of these drugs for other pediatric conditions coming from the disciplines of rheumatology, gastroenterology, and oncology.
Psoriasis pathophysiology: current concepts of pathogenesis
Current pathogenic concepts that have emerged from genetic, genomic, and cellular information obtained in basic studies and from clinical studies of selective immune targeting drugs are presented.
Therapies for childhood psoriasis.
With a prevalence of 2% of the general population of Europe and North America, psoriasis represents one of the most common and significant dermatologic disorders. While it has been claimed that
Cyclosporine Regimens in Plaque Psoriasis: An Overview with Special Emphasis on Dose, Duration, and Old and New Treatment Approaches
The attention will be focused on dose, treatment duration, novel schedules, and role in combination therapies, including the association with biologicals.